1-6 of 6
Emmanuelle Bourgeois Petit
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of CD20xCD3 Bispecific Antibodies with Ibrutinib and Lenalidomide Shows Efficacy in Relapsed/ Refractory CNS Lymphoma

Sandy Amorim, Benjamin Carpentier, Emmanuelle Bourgeois Petit, Benedicte Hivert, Vincent Thibaud, Alexandre Willaume, Laurent Pascal
Journal: Blood
Blood (2024) 144 (Supplement 1): 6453.
https://doi.org/10.1182/blood-2024-200197
Published: 2024
Journal Articles

Multicenter Open Label Phase 3 Benefit Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients. IFM2020-05

Arthur Bobin, Cyrille Hulin, Jerome Lambert, Aurore Perrot, Salomon Manier, Lydia Montes, Arnaud Jaccard, Lionel Karlin, Pascal Godmer, Denis Caillot, Thomas Chalopin, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Jacques Delaunay, Claire Dingremont, Alberto Santagostino, Mamoun Dib, Margaret Macro, Mourad Tiab, Kamel Laribi, Emmanuelle Bourgeois Petit, Claire Calmettes, Frederique Orsini Piocelle, Benoit Bareau, Reza Tabrizi, Laure Vincent, Mohamad Mohty, Cyrille Touzeau, Jill Corre, Philippe Moreau, Thierry Facon, Herve Avet Loiseau, Xavier Leleu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6741.
https://doi.org/10.1182/blood-2023-185699
Published: 2023
Journal Articles

Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype

Alexandre Willaume, Mourtaza Karimdjee, Sandy Amorim, Benjamin Carpentier, Benedicte Hivert, Emmanuelle Bourgeois-Petit, Pierre Gosset, Alban Bailliez, Laurent Pascal
Journal: Blood
Blood (2022) 140 (Supplement 1): 3835–3836.
https://doi.org/10.1182/blood-2022-159375
Published: 2022
Journal Articles

Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years). IFM2020-05/Benefit

Arthur Bobin, Jerome Lambert, Aurore Perrot, Salomon Manier, Lydia Montes, Arnaud Jaccard, Lionel Karlin, Pascal Godmer, Denis Caillot, Cyrille Hulin, Thomas Chalopin, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Dingremont, Alberto Santagostino, Mamoun Dib, Margaret Macro, Mourad Tiab, Kamel Laribi, Emmanuelle Bourgeois-Petit, Claire Calmettes, Frederique Orsini, Reza Tabrizi, Laure Vincent, Mohamad Mohty, Cyrille Touzeau, Jill Corre, Philippe Moreau, Thierry Facon, Herve Avet Loiseau, Xavier Leleu
Journal: Blood
Blood (2022) 140 (Supplement 1): 4423–4425.
https://doi.org/10.1182/blood-2022-168742
Published: 2022
Journal Articles

What Is the Benefit of Autologous Stem Cell Transplantation in Multiple Myeloma Beyond the Age of 65? Inputs from Real-World Data in the Emmy Cohort

Aurore Perrot, Olivier Decaux, Bruno Royer, Denis Caillot, Karim Belhadj Merzoug, Agathe Farge, Laurent Frenzel, Cécile Sonntag, Bohrane Slama, Emmanuelle Bourgeois-Petit, Philippe Moreau, Laurent Voillat, Odile Luycx, Lotfi Benboubker, Gian-Matteo Pica, Frederic Maloisel, Jean-Richard Eveillard, Caroline Algrin, Anna Schmitt, Ronan Garlantézec, Nathalie Texier, Raphael Germain, Marion Willaime, Cyrille Hulin
Journal: Blood
Blood (2022) 140 (Supplement 1): 4379–4381.
https://doi.org/10.1182/blood-2022-158484
Published: 2022
Journal Articles

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Véronique Tintillier-Colin, Nathalie Cambier, MD, Emmanuelle Bourgeois-Petit, MD, Christian Rose, MD, Gérard Forzy, MD, Jean-Loup Demory, MD, Agnès Charpentier, MD
Journal: Blood
Blood (2009) 114 (22): 1906.
https://doi.org/10.1182/blood.V114.22.1906.1906
Published: 2009